 leukaemia treatment hodgkin diseas experi british nation lymphoma investig object incid risk factor develop secondari acut leukaemia myelodysplasia patient british nation lymphoma investig studi hodgkin diseas patient hodgkin diseas studi februari novemb data novemb minimum follow period year design retrospect analysi multicentr trial data case-control life tabl method result case secondari leukaemia group patient overal risk year risk leukaemia chemotherapi radiotherapi differ risk leukaemia amount treatment number attempt treatment year risk leukaemia patient attempt treatment risk year patient lomustin ccnu case-control studi independ risk factor risk secondari leukaemia overal quantiti treatment exposur import risk factor treatment drug radiat leukaemogen treatment drug risk secondari leukaemia multipli treat patient unlik hodgkin diseas conclus avoid secondari leukaemia minor factor choic treatment hodgkin diseas